Contact the corresponding author for additional details regarding nSights
A 2025 study of 1,840 compounded GLP-1 patients (Nguyen et al., Journal of Managed Care & Specialty Pharmacy ) found that 11.3% reported at least one dosing error in the first 120 days of therapy
Gastrointestinal adverse effects are the most frequently reported and include: Nausea (very common, affecting more than 1 in 10 people according to the SmPC) Vomiting Diarrhoea Constipation Abdominal pain or discomfort These symptoms are usually mild to moderate, transient, and tend to improve over time as the body adjusts to the medication
It is also essential to assess patient satisfaction, as successful treatment for ED goes beyond efficacy and safety
Meng X, Song Q, Liu Z et al (2024) Neurotoxic -amyloid oligomers cause mitochondrial dysfunctionthe trigger for PANoptosis in neurons
Khan MS, Fonarow GC, McGuire DK et al (2020) Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization